Mexico Menopause Market Size & Outlook, 2024-2030

The menopause market in Mexico is expected to reach a projected revenue of US$ 511.0 million by 2030. A compound annual growth rate of 5.9% is expected of Mexico menopause market from 2025 to 2030.
Revenue, 2024 (US$M)
$367.2
Forecast, 2030 (US$M)
$511.0
CAGR, 2025 - 2030
5.9%
Report Coverage
Mexico

Mexico menopause market highlights

  • The Mexico menopause market generated a revenue of USD 333.1 million in 2022 and is expected to reach USD 511.0 million by 2030.
  • The Mexico market is expected to grow at a CAGR of 5.5% from 2023 to 2030.
  • In terms of segment, dietary supplements was the largest revenue generating treatment in 2022.
  • Dietary Supplements is the most lucrative treatment segment registering the fastest growth during the forecast period.


Menopause market data book summary

Market revenue in 2022USD 333.1 million
Market revenue in 2030USD 511.0 million
Growth rate5.5% (CAGR from 2022 to 2030)
Largest segmentDietary supplements
Fastest growing segmentDietary Supplements
Historical data2018 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationOTC pharma products, Dietary Supplements
Key market players worldwideBayer AG, AbbVie Inc, Abbott Laboratories, Nestle SA, Dr Reddy's Laboratories Ltd ADR, Theramex, Rainbow Light Nutritional Systems, Padagis


Other key industry trends

  • In terms of revenue, Mexico accounted for 2.1% of the global menopause market in 2022.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Latin America, Brazil menopause market is projected to lead the regional market in terms of revenue in 2030.
  • Argentina is the fastest growing regional market in Latin America and is projected to reach USD 103.8 million by 2030.

Dietary supplements was the largest segment with a revenue share of 98.11% in 2024. Horizon Databook has segmented the Mexico menopause market based on otc pharma products, dietary supplements covering the revenue growth of each sub-segment from 2018 to 2030.


Around 31%–50% of postmenopausal women suffer from night sweats and hot flashes in Mexico, which is similar to the scenario in the U.S. The onset of menopause is early, as compared to North American women; although the prevalence of hot flashes is lower due to dietary differences. However, changes in food habits due to westernized diets are expected to increase the demand for dietary supplements for menopausal symptoms in the country over the forecast period.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Menopause Market Scope

Menopause market segmentation & scope
Hormonal
Non-Hormonal
Dietary Supplements
Countries
UK
Sweden
Norway
Denmark
Australia
Thailand
Argentina
Saudi Arabia
UAE
Kuwait

Menopause Market Companies

Name Profile # Employees HQ Website

Mexico menopause market size, by treatment, 2018-2030 (US$M)

Mexico Menopause Market Outlook Share, 2024 & 2030 (US$M)

Mexico menopause market size, by treatment, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more